29K-34702-30253
2 vaccinations
3 coded responses
8 check-ins
3 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 934 / CA
- Registered
- 2021-03-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Dose 1 — Moderna
-
2021-02-18
Dose 2 — Moderna
-
2021-03-07
Registered in v-safe
-
2021-03-07
Survey response — day 14, dose 2MedDRA: Injection site pain, Lethargy — Feeling: GoodFree text: LethargyInjection site sorenessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-04
- 2021-05-20
-
2021-08-19
Survey response — 6 months, dose 2MedDRA: Hospitalisation, Mechanical ventilation, Myasthenia gravis, Neurotoxicity — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Symptoms: June 23 admitted for sudden onset myasthenia gravis thought to be related to receiving Opdivo immunotherapy - admitted to St Johns Providence Santa Monica CA and transferred and now at Barlow Respiratory Hospital Los Angeles, CA on ventilator · Healthcare visit (other): Neurotoxic reaction - on VentilatornMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-19
Report sent to call center — 6 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-27
-
2022-02-20
Survey response — 12 months, dose 2MedDRA: Death, Hospitalisation, Myasthenia gravis, Myocarditis, SARS-CoV-2 test negative, Unevaluable event — Feeling: Poor · Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: After Moderna received 2 half doses of Opdivo in June 2021 - developed severe myocarditis and Myasthenia Gravis. The end result after 230 days in acute hospital setting was death in Feb 2022. Tested Covid negative · Healthcare visit (other): June 23, 2020 to Feb 8, 2022MedDRA releases: 2024-11 · check-in free text available
-
2022-02-20
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2022-02-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Moderna | |
| 2 | 2021-02-18 | Moderna |
Call center
2 call center cases
2 unsuccessful
Free text
Release 5 — day 14, dose 2
Symptoms: LethargyInjection site soreness
Release 9 — 6 months, dose 2
Symptoms: June 23 admitted for sudden onset myasthenia gravis thought to be related to receiving Opdivo immunotherapy - admitted to St Johns Providence Santa Monica CA and transferred and now at Barlow Respiratory Hospital Los Angeles, CA on ventilator
Healthcare visit (other): Neurotoxic reaction - on Ventilatorn
Release 11 — 12 months, dose 2
Reports this person's death
Symptoms: After Moderna received 2 half doses of Opdivo in June 2021 - developed severe myocarditis and Myasthenia Gravis. The end result after 230 days in acute hospital setting was death in Feb 2022. Tested Covid negative
Healthcare visit (other): June 23, 2020 to Feb 8, 2022
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Neurotoxicity | ✓ | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Death | · | · | ✓ |
| SD | Hospitalisation | ✓ | · | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Lethargy | ✓ | ✓ | ✓ |
| SD | Mechanical ventilation | ✓ | · | ✓ |
| SD | Myasthenia gravis | ✓ | · | ✓ |
| SD | Myocarditis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release